Literature DB >> 1942113

End-stage renal disease and race: an overview and perspective.

R Ferguson1.   

Abstract

The epidemiology of end-stage renal disease (ESRD) in the United States is reviewed. Hypertension and diabetes as etiologic factors in ESRD in minorities are discussed, as is the question of a familial ESRD. It is hypothesized that diuretics as sole antihypertensive therapy in blacks may in the long term result in chronic volume contraction, increased sympathetic stimulation, and therefore, decreased renal function. As such, a rational basis for the long-term use of diuretics as the sole antihypertensive therapeutic in blacks becomes questionable at best.

Entities:  

Mesh:

Year:  1991        PMID: 1942113      PMCID: PMC2627098     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  16 in total

1.  Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota.

Authors:  L L Humphrey; D J Ballard; P P Frohnert; C P Chu; W M O'Fallon; P J Palumbo
Journal:  Ann Intern Med       Date:  1989-11-15       Impact factor: 25.391

2.  Diabetic renal disease in blacks--inevitable or preventable?

Authors:  S G Rostand
Journal:  N Engl J Med       Date:  1989-10-19       Impact factor: 91.245

3.  An areawide survey of treated end-stage renal disease.

Authors:  J S Mausner; J K Clark; B I Coles; H Menduke
Journal:  Am J Public Health       Date:  1978-02       Impact factor: 9.308

4.  The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.

Authors:  R Ferguson; C E Grim; T J Opgenorth
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

5.  The problem of diabetic renal failure in the United States: an overview.

Authors:  S Teutsch; J Newman; P Eggers
Journal:  Am J Kidney Dis       Date:  1989-01       Impact factor: 8.860

6.  Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population.

Authors:  J D Ordonez; R A Hiatt
Journal:  Nephron       Date:  1989       Impact factor: 2.847

7.  Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.

Authors:  W McClellan; E Tuttle; A Issa
Journal:  Am J Kidney Dis       Date:  1988-10       Impact factor: 8.860

8.  Epidemiologic features of treated end-stage renal disease in a large prepaid health plan.

Authors:  J D Ordonez; R A Hiatt; C P Quesenberry
Journal:  Am J Public Health       Date:  1990-01       Impact factor: 9.308

9.  A familial risk of chronic renal failure among blacks on dialysis?

Authors:  R Ferguson; C E Grim; T J Opgenorth
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

10.  Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.

Authors:  C C Cowie; F K Port; R A Wolfe; P J Savage; P P Moll; V M Hawthorne
Journal:  N Engl J Med       Date:  1989-10-19       Impact factor: 91.245

View more
  2 in total

1.  Community outreach: a call for community action.

Authors:  Paul Crawford; Randall Maxey; Keith Dacosta
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

2.  Kidney disease in elderly minorities.

Authors:  Chamberlain I Obialo; Sharon Allison-Ottey
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.